Headache News and Research

Latest Headache News and Research

Mild TBI may increase risk of postconcussive symptoms in children

Children who experience mild traumatic brain injury may be more likely to show increases in symptoms over time that could impact quality of life, more so than children who experience an orthopedic injury. Injury severity could play a role.

7 Mar 2012

Concussion in kids may lead to memory and cognitive problems at school later in life

The researchers from Nationwide Children’s Hospital and The Ohio State University looked at 186 children aged 8 to 15 who experienced concussion - most commonly in a fall or while playing sports - or other brain injury from a car accident or other causes. The children’s parents were asked to fill out a standard questionnaire to assess their child’s cognitive and physical status before the concussion, and again two weeks, three months and a year later. These responses were compared to those from parents of 99 similar children who came into the emergency room with orthopedic injuries.

7 Mar 2012

Persistent postconcussion symptoms more likely in children with TBIs

Children with mild traumatic brain injuries appear more likely to have persistent postconcussion symptoms, including cognitive complaints such as inattention and forgetfulness, which can affect quality of life, according to a report published Online First by Archives of Pediatrics & Adolescent Medicine, one of the JAMA/Archives journals.

6 Mar 2012

Meda announces positive results from three MP29-02 studies on allergic rhinitis

Meda announced today positive results of three studies of MP29-02 (tentatively called Dymista), a novel intranasal formulation of azelastine hydrochloride and fluticasone propionate.

5 Mar 2012

Study: Bioavailability similar among four subcutaneous IgG preparations

Data presented by CSL Behring today suggest that the bioavailability of immunoglobulin G (IgG) therapies is consistent when patients with primary immunodeficiencies switch from one IgG product to another by the subcutaneous route.

5 Mar 2012

EC grants marketing authorization for Baxter's VEPACEL to treat influenza A

Baxter International Inc. announced today that the European Commission (EC) has granted marketing authorization for VEPACEL in all European Union (EU) Member States, as well as Iceland, Liechtenstein and Norway.

From Baxter International Inc. 2 Mar 2012

Preliminary results from Genentech's ACTEMRA monotherapy study on RA

Genentech, a member of the Roche Group, today announced that preliminary results from the ADACTA (ADalimumab ACTemrA) study showed that patients who received ACTEMRA (tocilizumab) as monotherapy achieved a significantly greater reduction in disease activity after 24 weeks than those given adalimumab monotherapy.

2 Mar 2012

Positive results from AltheRx Solabegron Phase II study on overactive bladder

AltheRx Pharmaceuticals, a privately-held clinical development company, presented positive results from its Phase II study of Solabegron in overactive bladder (OAB) at the European Association of Urology Congress in Paris.

1 Mar 2012

Physiological problems stemming from concussions may persist

A study recently published by the University of Kentucky's Scott Livingston shows that physiological problems stemming from a concussion may continue to present in the patient even after standard symptoms subside.

1 Mar 2012

NEJM publishes results from two Jakafi Phase III studies on MF

The New England Journal of Medicine (NEJM) today published results from two Phase III studies (COMFORT-I and COMFORT-II) of Jakafi (ruxolitinib), a JAK1 and JAK2 inhibitor recently approved by the Food and Drug Administration (FDA) for the treatment of intermediate or high-risk myelofibrosis.

1 Mar 2012

Bayer receives FDA approval for lower dose formulation of ANGELIQ

Bayer HealthCare Pharmaceuticals Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved a lower dose formulation of ANGELIQ (drospirenone and estradiol) tablets to treat moderate to severe vasomotor symptoms due to menopause in women who have a uterus.

29 Feb 2012

Gedeon Richter and Forest Labs' cariprazine Phase III trials on schizophrenia meet primary endpoint

Forest Laboratories, Inc. and Gedeon Richter Plc. today announced positive top-line results in 2 Phase III clinical trials of cariprazine (RGH-188) for the treatment of acute exacerbation of schizophrenia.

28 Feb 2012

Typhoid on Christmas Island

As of now people seeking asylum on Christmas Island will have to wait to be transferred to mainland Australia, after typhoid fever was detected on the island.

27 Feb 2012

FDA issues complete response letter for Watson's progesterone vaginal gel 8% NDA

Watson Pharmaceuticals, Inc. and Columbia Laboratories, Inc. today confirmed that, as expected, Watson has received a complete response letter from the U.S. Food and Drug Administration (FDA) for its New Drug Application (NDA 22-139) for progesterone vaginal gel 8% for use in the reduction of risk of preterm birth in women with a singleton gestation and a short uterine cervical length in the mid-trimester of pregnancy.

27 Feb 2012

ATI commences European trial of neurostimulation system for migraine

Autonomic Technologies, Inc. (ATI), the developer of a novel miniaturized implantable stimulator for severe headaches, today announced initiation of a study in Europe to evaluate the safety and efficacy of the company's investigational neurostimulation system for the treatment of high frequency, high disability migraine.

27 Feb 2012

Chronic pain patients at high-risk for comorbid substance abuse benefit from 3-week program

Research presented at the American Academy of Pain Medicine's 28th Annual Meeting shows that substance use education incorporated into a cognitive behavioral rehabilitation programming is effective to improve pain and function for the chronic pain patient at high-risk for comorbid substance abuse.

27 Feb 2012

Dopamine therapy can boost creativity in patients with Parkinson's

Some Parkinson's Disease patients can suddenly become creative when they take dopamine therapy, producing pictures, sculptures, novels and poetry. But their new-found interests can become so overwhelming that they ignore other aspects of their everyday life, such as daily chores and social activities, according to research published in the March issue of the European Journal of Neurology.

24 Feb 2012

BWH researchers publish findings that question reliability of new CMS quality measure

Researchers at Brigham and Women's Hospital (BWH) have published findings that question the reliability of a new Centers for Medicare and Medicaid Services (CMS) quality measure.

24 Feb 2012

Migraine and depression link found for women

A new study finds that women who suffer from migraine headaches may be about 40% more likely to develop depression than women who have never had migraines. The results will be presented in April at the annual meeting of the American Academy of Neurology at New Orleans.

23 Feb 2012

Pfizer responds to CDC’S ACIP discussion related to use of Prevnar 13 in adults over 50

Pfizer Inc. issued the following statement in response to today's discussion by the Centers for Disease Control and Prevention's (CDC) Advisory Committee on Immunization Practices (ACIP) regarding the use of Prevnar 13 (Pneumococcal 13-valent Conjugate Vaccine)in adults 50 years of age and older.

23 Feb 2012

Headache News and Research

Latest Headache News and Research

Mild TBI may increase risk of postconcussive symptoms in children

Concussion in kids may lead to memory and cognitive problems at school later in life

Persistent postconcussion symptoms more likely in children with TBIs

Meda announces positive results from three MP29-02 studies on allergic rhinitis

Study: Bioavailability similar among four subcutaneous IgG preparations

EC grants marketing authorization for Baxter's VEPACEL to treat influenza A

Preliminary results from Genentech's ACTEMRA monotherapy study on RA

Positive results from AltheRx Solabegron Phase II study on overactive bladder

Physiological problems stemming from concussions may persist

NEJM publishes results from two Jakafi Phase III studies on MF

Bayer receives FDA approval for lower dose formulation of ANGELIQ

Gedeon Richter and Forest Labs' cariprazine Phase III trials on schizophrenia meet primary endpoint

Typhoid on Christmas Island

FDA issues complete response letter for Watson's progesterone vaginal gel 8% NDA

ATI commences European trial of neurostimulation system for migraine

Chronic pain patients at high-risk for comorbid substance abuse benefit from 3-week program

Dopamine therapy can boost creativity in patients with Parkinson's

BWH researchers publish findings that question reliability of new CMS quality measure

Migraine and depression link found for women

Pfizer responds to CDC’S ACIP discussion related to use of Prevnar 13 in adults over 50

The future of automation: Machine learning–driven hepatocyte and organoid counting

From street to lab: Advancing controlled substance testing with handheld Raman and FTIR

Reimagining light scattering for biotherapeutics

Headache News and Research

Latest Headache News and Research

The future of automation: Machine learning–driven hepatocyte and organoid counting

From street to lab: Advancing controlled substance testing with handheld Raman and FTIR

Reimagining light scattering for biotherapeutics

Newsletters you may be interested in